Implementation determinants of safer smoking supplies in U.S. syringe services programs.

William H Eger, Angel K Gomez, Kirstin Kielhold, Tyler S Bartholomew, Angela R Bazzi
Author Information
  1. William H Eger: School of Social Work, San Diego State University, San Diego, CA, USA.
  2. Angel K Gomez: AIDS United, Washington, D.C, USA.
  3. Kirstin Kielhold: School of Public Health, San Diego State University, San Diego, CA, USA.
  4. Tyler S Bartholomew: Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA.
  5. Angela R Bazzi: Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, CA, USA. abazzi@health.ucsd.edu. ORCID

Abstract

BACKGROUND: The prevalence of smoking opioids and other unregulated drugs has increased across the United States (U.S.) since 2000. Improved access to safer smoking supplies may reduce the health consequences of inhalation while helping to engage more people who use drugs in syringe services programs (SSPs); however, the landscape of safer smoking supply implementation is understudied.
METHODS: From November 2023-January 2024, we surveyed representatives of U.S. SSPs to assess safer smoking supply implementation across contextual domains of the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework. Descriptive statistics were used to describe determinants across the phases of safer smoking supply implementation. Poisson regression identified factors associated with implementation.
RESULTS: Among 118 organizations responding to the survey, most received state funding (83%), were community-based organizations (CBOs; 74%), and served urban jurisdictions (62%). The majority (67%) were already providing safer smoking supplies; 16% were exploring implementation and 11% were not. On average, safer smoking supply implementation occurred more recently than the provision of syringes (1-2 years ago vs. > 5 years ago), with participant request being the most common motivation for implementation (84%). Additional facilitators of safer smoking supply implementation were organizational prioritization (65%) and internal leadership support (57%). Factors significantly associated with safer smoking supply implementation included being from the Northeastern or Western regions (vs. the U.S. South), serving exurban communities, being a CBO, receiving foundation funding, receiving private donations from fundraising, and offering syringes and other injection alternatives (e.g., safer snorting supplies). Receiving federal funding, fear of external community opposition, internal leadership opposition, and respondent uncertainty about changing demand for safer smoking supplies (vs. perceiving that demand has not changed) were negatively associated with implementation.
CONCLUSIONS: Determinants in the inner context, like organizational prioritization of safer smoking supplies and internal leadership support, may facilitate safer smoking supply implementation, while specific outer context factors (e.g., funding, regional policies) may inhibit implementation. Flexible policies and funding structures and further research to build and disseminate evidence on the benefits of safer smoking supplies are needed to expand the implementation and scale-up of this prevention service within U.S. SSPs.

Keywords

References

  1. Drug Alcohol Depend. 2024 Oct 1;263:111419 [PMID: 39216201]
  2. Prev Chronic Dis. 2014 Jan 23;11:130184 [PMID: 24456645]
  3. MMWR Morb Mortal Wkly Rep. 2024 Feb 15;73(6):124-130 [PMID: 38358969]
  4. Addict Sci Clin Pract. 2024 Mar 25;19(1):21 [PMID: 38528570]
  5. Transl Res. 2021 Aug;234:159-173 [PMID: 33746108]
  6. Am J Prev Med. 2021 Nov;61(5 Suppl 1):S118-S129 [PMID: 34686281]
  7. Adm Policy Ment Health. 2011 Jan;38(1):4-23 [PMID: 21197565]
  8. Implement Sci. 2023 Aug 3;18(1):33 [PMID: 37537665]
  9. Drug Alcohol Depend. 2024 Jun 1;259:111318 [PMID: 38692135]
  10. Am J Prev Med. 2021 Nov;61(5):738-749 [PMID: 34218964]
  11. Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350 [PMID: 33965972]
  12. Lancet Reg Health Am. 2024 May 06;34:100757 [PMID: 38745887]
  13. Subst Abuse Treat Prev Policy. 2021 Oct 18;16(1):79 [PMID: 34663374]
  14. Clin Infect Dis. 2024 Oct 15;79(4):1109-1116 [PMID: 39078273]
  15. Drug Alcohol Depend Rep. 2024 Dec 31;14:100317 [PMID: 39877805]
  16. Am J Prev Med. 2017 Dec;53(6):919-922 [PMID: 28801014]
  17. Clin Infect Dis. 2023 Jun 16;76(12):2134-2139 [PMID: 36757712]
  18. Harm Reduct J. 2017 Jul 26;14(1):51 [PMID: 28747189]
  19. Implement Sci. 2019 Jan 5;14(1):1 [PMID: 30611302]
  20. Implement Sci. 2024 Feb 28;19(1):22 [PMID: 38419058]
  21. Implement Sci. 2017 Sep 6;12(1):111 [PMID: 28877746]
  22. Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109124 [PMID: 34781096]
  23. Drug Alcohol Depend. 2024 Feb 1;255:111053 [PMID: 38128362]
  24. Addiction. 2023 Dec;118(12):2477-2485 [PMID: 37705148]
  25. Int J Drug Policy. 2020 Nov;85:102923 [PMID: 32920424]
  26. Harm Reduct J. 2022 Sep 22;19(1):103 [PMID: 36138407]
  27. Drug Alcohol Depend. 2021 Oct 1;227:109003 [PMID: 34482046]
  28. PLoS One. 2024 May 22;19(5):e0303403 [PMID: 38776268]
  29. Harm Reduct J. 2023 Feb 28;20(1):26 [PMID: 36855181]
  30. Public Health Rep. 2020 Jul/Aug;135(1_suppl):128S-137S [PMID: 32735195]
  31. Am J Epidemiol. 2004 Apr 1;159(7):702-6 [PMID: 15033648]
  32. Harm Reduct J. 2017 May 18;14(1):28 [PMID: 28521829]
  33. Am J Public Health. 2019 Nov;109(11):1564-1567 [PMID: 31536408]
  34. Am J Public Health. 2024 Apr;114(4):435-443 [PMID: 38478864]

Grants

  1. R36 DA061013/NIDA NIH HHS
  2. T32 DA023356/NIDA NIH HHS
  3. R36DA061013/NIDA NIH HHS
  4. T32DA023356/NIDA NIH HHS

Word Cloud

Created with Highcharts 10.0.0smokingsaferimplementationsuppliessupplyUSfundingacrossmayservicesprogramsSSPsImplementationassociatedvsinternalleadershipdrugssyringedeterminantsfactorsorganizationssyringesagoorganizationalprioritizationsupportreceivingegoppositiondemandcontextpoliciesBACKGROUND:prevalenceopioidsunregulatedincreasedUnitedStatessince2000ImprovedaccessreducehealthconsequencesinhalationhelpingengagepeopleusehoweverlandscapeunderstudiedMETHODS:November2023-January2024surveyedrepresentativesassesscontextualdomainsExplorationPreparationSustainmentEPISframeworkDescriptivestatisticsuseddescribephasesPoissonregressionidentifiedRESULTS:Among118respondingsurveyreceivedstate83%community-basedCBOs74%servedurbanjurisdictions62%majority67%alreadyproviding16%exploring11%averageoccurredrecentlyprovision1-2 years > 5 yearsparticipantrequestcommonmotivation84%Additionalfacilitators65%57%FactorssignificantlyincludedNortheasternWesternregionsSouthservingexurbancommunitiesCBOfoundationprivatedonationsfundraisingofferinginjectionalternativessnortingReceivingfederalfearexternalcommunityrespondentuncertaintychangingperceivingchangednegativelyCONCLUSIONS:DeterminantsinnerlikefacilitatespecificouterregionalinhibitFlexiblestructuresresearchbuilddisseminateevidencebenefitsneededexpandscale-uppreventionservicewithinOpioidsSaferSmokingSyringe

Similar Articles

Cited By